Table 1.
Top 40 genes with recurrent ASE in an AML cohort of 209 patients
Gene | No. of patients* | Evaluated cases† | Samples, %‡ | COSMIC§ | Myeloid differentiation§ |
---|---|---|---|---|---|
GATA2 | 66 | 178 | 37 | Yes | Yes |
THBS1 | 36 | 124 | 29 | No | Yes |
MYH11 | 20 | 199 | 10 | Yes | No |
CA2 | 13 | 126 | 10 | No | Yes |
MECOM | 13 | 186 | 7 | Yes | No |
SH3PXD2A | 13 | 195 | 7 | No | Yes |
CDKN2A | 11 | 102 | 11 | Yes | No |
JAG1 | 11 | 201 | 5 | No | Yes |
L3MBTL3 | 11 | 156 | 7 | No | Yes |
TRIM58 | 11 | 183 | 6 | No | Yes |
CIB1 | 10 | 160 | 6 | No | Yes |
FLT3 | 10 | 175 | 6 | Yes | No |
HIP1 | 9 | 198 | 5 | Yes | No |
PDE4DIP | 9 | 198 | 5 | Yes | No |
HSP90AB1 | 8 | 147 | 5 | Yes | No |
L3MBTL1 | 8 | 155 | 5 | No | Yes |
MGMT | 8 | 150 | 5 | Yes | No |
RUNX1 | 7 | 188 | 4 | Yes | Yes |
USP6 | 7 | 149 | 5 | Yes | No |
CD101 | 6 | 174 | 3 | No | Yes |
FAT1 | 6 | 202 | 3 | Yes | No |
IRF8 | 6 | 165 | 4 | No | Yes |
MEIS1 | 6 | 156 | 4 | No | Yes |
NPM1 | 6 | 134 | 4 | Yes | No |
ABL1 | 5 | 153 | 3 | Yes | No |
CIITA | 5 | 196 | 3 | Yes | No |
DNMT3A | 5 | 188 | 3 | Yes | No |
FAM20C | 5 | 184 | 3 | No | Yes |
LTF | 5 | 188 | 3 | No | Yes |
MYB | 5 | 161 | 3 | Yes | No |
PML | 5 | 181 | 3 | Yes | Yes |
PRDM2 | 5 | 151 | 3 | Yes | No |
RMI2 | 5 | 148 | 3 | Yes | No |
RPN1 | 5 | 159 | 3 | Yes | No |
ZFHX3 | 5 | 201 | 2 | Yes | No |
AKT1 | 4 | 178 | 2 | Yes | No |
BAX | 4 | 110 | 4 | Yes | No |
BRCA1 | 4 | 170 | 2 | Yes | No |
KMT2C | 4 | 162 | 2 | Yes | Yes |
KNSTRN | 4 | 158 | 3 | Yes | No |
No. of patients presenting with ASE for that gene.
No. of patients with SNVs that could be evaluated in that gene.
Determined by dividing no. of patients by no. of evaluated cases.
Indicates whether the gene is found in COSMIC database or is involved in myeloid differentiation (Gene Ontology database: 0030099). Note that reportedly imprinted genes (according to GeneImprint) were filtered out.